Greg Scott - SynBioBeta 2020

Greg founded ChinaBio^® Group in 2007 to help life science companies and investors achieve success in China. ChinaBio^® works with US, European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China. ChinaBio^® has also organized over 30 conferences in China focused on investment and partnering, including the ChinaBio^® Partnering Forum which draws over 1000 attendees from around the world to China each spring. Greg is also co-founder of two investment groups that have funded over 50 biotechnology and medical device companies in the US and China, and Executive Editor of ChinaBio^® Today, a widely read newsletter covering the China life science industry. He also serves on the boards of a medical device and cancer drug company, and formerly the BayHelix Group, a group of China-focused life science executives. Headquartered in Shanghai, ChinaBio^® has staff in San Diego, Palo Alto, and Basel, Switzerland.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.